Fig. 8

Enrichments of DNMT1, HDAC1, and SUV39H1 in the TLR4 promoter in CD14⁺ monocytes. a–d The relative enrichment levels of RFX1 (a), DNMT1 (b), HDAC1 (c), and SUV39H1 (d) in TLR4 promoter with RFX1 binding region were measured by ChIP-qPCR in CAD CD14⁺ monocytes. e–h The enrichments of RFX1 (e), DNMT1 (f), HDAC1 (g), and SUV39H1 (h) in TLR4 promoter with RFX1 binding region were measured by ChIP-qPCR in the LDL-treated CD14⁺ monocytes. The fold changes were shown between LDL treatment with control group. All values are the average of at least three biological replicates, and the data shown are the means ± SDs. *P < 0.05; **P < 0.01 relative to control